{
  "pmcid": "12449477",
  "sha256": "401f07b0ba3bc33e3f939fbdf3be052ea09e3b91430dd4f07567f37c2d1b2fe1",
  "timestamp_utc": "2025-11-09T15:42:37.047108+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 16.95692964824121,
    "reading_ease": 8.933987437185948,
    "word_count": 199
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 1,
        "evidence": "treatment with anti-PD-L1-CRT"
      },
      "Objective": {
        "score": 1,
        "evidence": "Our research aimed to unravel the nuanced mechanisms involved in both immune attack and evasion induced by anti-PD-L1-CRT with single cell spatial transcriptome."
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "Posttreatment alterations included a significant increase in CXCL9 + cells and CXCL13 +â€‰T cells, particularly around tumour cells."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 3,
    "max_score": 25
  }
}